98%
921
2 minutes
20
Introduction: Central serous chorioretinopathy (CSC) is a prevalent exudative maculopathy; however, exact details of its incidence and a global estimate of its annual incidence are lacking. It is paramount to understand the details of the incidence of CSC when discussing its societal and personal impact, the impact of medicine shortages and initiatives for healthcare policies, and organization of retinal service.
Methods: In this study, we systematically reviewed the literature on the incidence of CSC and performed meta-analyses to provide an age-stratified estimate of its incidence. By using population statistics from the United Nations Population Division, we were able to estimate the global and country-specific incidence of CSC in 2025 and forecast until 2050.
Results: Seven eligible studies included a total of 324,954 new patients with CSC during their time of investigation. The summary estimate incidence rates per 100,000 person-years were 47.8 (95% confidence interval [CI] 31.7-61.7) for individuals 30-39 years, 71.8 (95% CI 41.7-109.7) for individuals 40-49 years, 58.5 (95% CI 29.9-96.1) for individuals 50-59 years, and 36.2 (95% CI 16.8-62.6) for individuals 60-69 years. We confirmed male sex as a risk factor (odds ratio 2.73, P < 0.0001), and found that male individuals were significantly younger than female individuals at onset of CSC (average difference of 3.30 years, P < 0.0001). We estimated that in 2025, 1.97 million individuals globally will develop CSC, and that the incidence will increase to 2.03 million individuals in 2030, 2.30 million individuals in 2040, and 2.43 million individuals in 2050. The CSC incidence peaked between 40 and 49 years underscoring the significance in working-age individuals.
Conclusion: Numbers presented in this study highlight that CSC is one of the more prevalent maculopathies in our world and underscores the importance of education, research, and healthcare planning related to CSC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s40123-025-01220-0 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413349 | PMC |
Br J Ophthalmol
September 2025
Lions Aravind Institute of Community Ophthalmology, Aravind Eye Care System, Madurai, India
Background: The Vision Centre (VC) model evolved to meet primary eye care needs in rural and underprivileged communities, overcoming workforce and resource challenges. Despite over two decades of operation, its impact is not well-documented. We evaluated its effectiveness by comparing prevalence of visual impairment (VI), eyecare utilisation and service coverage among residents within and beyond a 5 km radius of VCs in Theni district, India.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Department of General Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Horner syndrome (HS), a rare complication of endoscopic thyroid surgery (ETS), manifests as ptosis, miosis, and anhidrosis resulting from oculosympathetic pathway disruption. This study explores HS etiology through two case reports and literature analysis. Case 1 involved a 43-year-old female who underwent unilateral thyroidectomy via a bilateral areolar approach for a thyroid oncocytic adenoma.
View Article and Find Full Text PDFCNS Drugs
September 2025
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Objective: To characterize multinational trends and patterns of opioid analgesic prescribing by sex and age.
Design, Setting, And Participants: We studied opioid analgesic prescribing from 2001 to 2019 with common protocol using population-based databases from eighteen countries and one special administrative region.
Main Outcome Measures: We measured opioid prescribing by geographical region, sex and age, estimating annual prevalent, incident, and nonincident opioid prescribing per 100 population with a 95% confidence interval (CI) and meta-analyzed the multinational and regional opioid prescribing with a random-effects model.
Eur Radiol
August 2025
Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Objectives: To assess the impact of reconstruction parameters on AI's performance in detecting and classifying risk-dominant nodules in a baseline low-dose CT (LDCT) screening among a Chinese general population.
Materials And Methods: Baseline LDCT scans from 300 consecutive participants in the Netherlands and China Big-3 (NELCIN-B3) trial were included. AI analyzed each scan reconstructed with four settings: 1 mm/0.
Nat Med
August 2025
Queen's University Cancer Research Institute, Cancer Care and Epidemiology, Kingston, Ontario, Canada.